Mira Pharmaceuticals (MIRA) Shares Outstanding (Diluted Average) (2022 - 2025)

Mira Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 4 years of filings, most recently posting $19.3 million for Q3 2025.

• Shares Outstanding (Diluted Average) for Q3 2025 came in at $19.3 million, up 27.89% year-over-year; the trailing twelve-month figure through Sep 2025 was $19.3 million (up 27.89% YoY), and the FY2024 annual result was $15.4 million, up 10.91% from the prior year.
• Shares Outstanding (Diluted Average) came in at $19.3 million for Q3 2025 at Mira Pharmaceuticals, up from $17.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $19.3 million in Q3 2025 to a low of $13.1 million in Q2 2022.
• The 4-year median for Shares Outstanding (Diluted Average) is $14.9 million (2024), against an average of $15.4 million.
• Across the five-year window, Shares Outstanding (Diluted Average) dropped 20.73% in 2023 and increased 27.89% in 2025, its largest moves.
• Mira Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $17.6 million in 2022, then decreased by 20.73% to $13.9 million in 2023, then increased by 10.91% to $15.4 million in 2024, then gained by 24.8% to $19.3 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $19.3 million (Q3 2025), $17.0 million (Q2 2025), and $16.6 million (Q1 2025), per Business Quant data.